Drug Shortage Report for PERSANTINE
Report ID | 181380 |
Drug Identification Number | 00637734 |
Brand name | PERSANTINE |
Common or Proper name | Persantine |
Company Name | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE |
Market Status | MARKETED |
Active Ingredient(s) | DIPYRIDAMOLE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5´s |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-02-01 |
Actual start date | |
Estimated end date | 2024-02-01 |
Actual end date | 2024-02-08 |
Shortage status | Resolved |
Updated date | 2024-02-28 |
Company comments | Shortage resolved, Persantin is available in the market, manufacture issues resolved |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | ARABELLASTR 17 MUNICH, -- GERMANY 81925 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-02-28 | French | Compare |
v6 | 2024-02-28 | French | Compare |
v5 | 2024-02-28 | English | Compare |
v4 | 2023-07-18 | English | Compare |
v3 | 2023-02-02 | English | Compare |
v2 | 2023-01-18 | French | Compare |
v1 | 2023-01-18 | English | Compare |
Showing 1 to 7 of 7